go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Washington, DC rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $1,621,810 · 10th–90th $562,341$2,137,9620%20%40%10th90th$1,621,810Professionalmedian $562,341 · 10th–90th $562,341$588,8440%50%90th$562,341$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$1,621,810.10
Typical High
$2,137,962.09
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$588,843.66
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$741,310.24
Median
$851,138.04
Typical High
$1,737,800.83
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$478,630.09
Median
$562,341.33
Typical High
$602,559.59
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$630,957.34
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$537,031.80
Typical High
$851,138.04